Register
Login

Trending Topic

Musculoskeletal AI image
16 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Samantha Cooray, Alexander Deng, Tim Dong

There is much excitement about the deployment of artificial intelligence (AI) in healthcare, and the musculoskeletal field is no exception. In this article, we introduce some of the latest developments relating to osteoarthritis (OA), osteoporosis, rheumatoid arthritis (RA) (as an example of inflammatory arthritis), connective tissue disease (CTD), Ehlers–Danlos syndrome (EDS) and musculoskeletal surgical interventions. […]

Brian Kim: Advances in Therapeutics for Chronic Pruritus

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Oct 19th 2021

Touch Medical Media coverage of data presented at EADV 2021:

In this interview, we talk with Dr Brian Kim (Washington University School of Medicine, St. Louis, MO, USA) about the current unmet need in the treatment of pruritus and how the therapeutic landscape is changing.

His presentation entitled ‘New frontiers in itch therapy‘ was given at the EADV 30th Congress, 29 Sep – 2 Oct 2021.

Questions

  1. Could you give us an overview of the health burden of chronic pruritus in atopic dermatitis and the unmet needs in its treatment? (0:17)
  2. How are recent advances changing the therapeutic landscape for pruritus? (1:17)

Disclosures: Dr Brian Kim has acted as a consultant for AbbVie, AstraZeneca, Cara Therapeutics, Galderma, GlaxoSmithKline, LEO Pharma, Eli Lilly, Pfizer, Regeneron, Sanofi and Trevi Therapeutics and undertaken contracted research for Cara Therapeutics and LEO Pharma.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Gina Furnival.

Filmed in coverage of the EADV’s 30th Congress, 29 Sep – 2 Oct 2021.

This content was developed by Touch Medical Media and is not affiliated with the  European Academy of Dermatology & Venereology  (EADV) or the congress. 

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup